CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,500 enrolled
Drug / intervention
Iron +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01119612
NCT01119612N/ACompleted
CompareCT.gov

Prenatal Iron Supplements: Safety and Efficacy in Tanzania

Harvard School of Public Health (HSPH)·interventional·Posted May 7, 2010·Updated Apr 24, 2015

In Brief

A clinical study evaluating Iron and Placebo for Malaria and Anemia. Completed, enrolled 1,500 participants across 1 site.

Detailed Summary

The purpose of this study is to determine safety and efficacy of prenatal iron supplementation in an area of high malaria burden among women who are not anemic or iron deficient.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria, Anemia
CountriesTanzania
CollaboratorsMuhimbili University of Health and Allied Sciences

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 7, 2010
Enrollment StartSep 1, 2010
Primary CompletionMar 1, 2013
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 16.2 years ago

Interventions

Irondietary

Daily oral dose of 60 mg from enrollment until delivery

Placeboother

Daily oral dose from enrollment until delivery